Skip to main content
2 May 2025
Last updated:
Tuesday 29 April 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Pharma slow to adopt SE incorporation
Read more
How surrogate markers impact drug development
Read more
Curbing the use of unproven cellular therapies
Read more
Ownership lessons for European biotechs
Read more
Sourcing antibiotics from the nematode worm
Read more
Innovation spreads across the oncology sector
Read more
European pharma plans new strategies for R&D
Read more
Using nanotechnology to improve AIDS medication
Read more
Patch up the pain: A case study in transdermal drug delivery
Read more
Non-governmental drug assessments in the US
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
32
Page
33
Page
34
Page
35
Current page
36
Page
37
Page
38
Page
39
Page
40
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form